Implantable Devices for the Treatment of Breast Cancer.
biopolymer
chemotherapy
implantable drug delivery devices
localized therapy
nanocomposite materials
Journal
Journal of nanotheranostics
ISSN: 2624-845X
Titre abrégé: J Nanotheranostics
Pays: Switzerland
ID NLM: 9918402287206676
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
medline:
1
3
2022
pubmed:
1
3
2022
entrez:
21
8
2023
Statut:
ppublish
Résumé
Breast cancer is one of the leading causes of death in the female population worldwide. Standard treatments such as chemotherapy show noticeable results. However, along with killing cancer cells, it causes systemic toxicity and apoptosis of the nearby healthy cells, therefore patients must endure side effects during the treatment process. Implantable drug delivery devices that enhance therapeutic efficacy by allowing localized therapy with programmed or controlled drug release can overcome the shortcomings of conventional treatments. An implantable device can be composed of biopolymer materials, nanocomposite materials, or a combination of both. This review summarizes the recent research and current state-of-the art in these types of implantable devices and gives perspective for future directions.
Identifiants
pubmed: 37600442
doi: 10.3390/jnt3010003
pmc: PMC10438892
mid: NIHMS1863419
doi:
Types de publication
Journal Article
Langues
eng
Pagination
19-38Subventions
Organisme : NIAID NIH HHS
ID : R01 AI147731
Pays : United States
Organisme : NINDS NIH HHS
ID : R15 NS108815
Pays : United States
Organisme : NIMHD NIH HHS
ID : U54 MD012393
Pays : United States
Déclaration de conflit d'intérêts
Conflicts of Interest: The authors declare no conflict of interest.
Références
Clin Cancer Res. 2009 Jan 1;15(1):131-9
pubmed: 19118040
Adv Healthc Mater. 2022 Jan;11(1):e2101415
pubmed: 34719861
Int J Nanomedicine. 2012;7:4391-408
pubmed: 22927757
J Pharm Pharm Sci. 2011;14(1):67-77
pubmed: 21501554
Artif Cells Nanomed Biotechnol. 2018 Aug;46(5):899-916
pubmed: 28914553
Artif Cells Nanomed Biotechnol. 2018;46(sup3):S755-S762
pubmed: 30260234
Nat Mater. 2016 Oct;15(10):1128-38
pubmed: 27454043
Nat Commun. 2021 Aug 26;12(1):5138
pubmed: 34446702
Clin Breast Cancer. 2016 Oct;16(5):335-343
pubmed: 27268750
Adv Mater. 2010 Nov 24;22(44):4925-43
pubmed: 20818618
Sci Rep. 2021 Jun 17;11(1):12798
pubmed: 34140620
Biomaterials. 2016 Oct;104:129-37
pubmed: 27449949
Med Dosim. 2016 Autumn;41(3):253-7
pubmed: 27545009
Lab Chip. 2011 Aug 21;11(16):2744-52
pubmed: 21698338
J Immunol Res. 2019 May 9;2019:4260987
pubmed: 31211147
Nanoscale. 2012 Sep 21;4(18):5686-93
pubmed: 22875402
J Mater Sci Mater Med. 2010 Sep;21(9):2701-10
pubmed: 20644983
Ann Surg Oncol. 2012 Jan;19(1):199-206
pubmed: 21769471
Transplantation. 2020 Apr;104(4):715-723
pubmed: 31764762
Artif Cells Blood Substit Immobil Biotechnol. 2010 Oct;38(5):230-49
pubmed: 20677900
Exp Hematol. 2022 Mar;107:38-50
pubmed: 34952140
BMC Bioinformatics. 2020 Jul 6;21(1):288
pubmed: 32631229
Expert Opin Drug Deliv. 2010 Apr;7(4):429-44
pubmed: 20331353
Pharm Dev Technol. 2018 Dec;23(10):953-963
pubmed: 30084277
Br J Surg. 2007 Oct;94(10):1189-200
pubmed: 17701939
Bioengineering (Basel). 2021 Dec 09;8(12):
pubmed: 34940358
Int J Implant Dent. 2021 Nov 12;7(1):110
pubmed: 34767122
Sci Rep. 2016 Feb 04;6:20543
pubmed: 26841709
Acta Biochim Biophys Sin (Shanghai). 2021 Dec 8;53(12):1625-1639
pubmed: 34586349
Int J Biol Macromol. 2015 Jan;72:1313-22
pubmed: 25450550
Theranostics. 2020 Aug 29;10(23):10652-10664
pubmed: 32929372
Int J Pharm. 2021 Dec 15;610:121205
pubmed: 34670119
Oncologist. 2004;9 Suppl 2:3-8
pubmed: 15161985
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Expert Rev Mol Diagn. 2006 May;6(3):307-18
pubmed: 16706735
Int J Cancer. 2018 Sep 15;143(6):1470-1482
pubmed: 29659011
Breast Cancer (Auckl). 2015 Sep 27;9(Suppl 2):17-34
pubmed: 26462242
J Control Release. 2010 Jun 15;144(3):280-7
pubmed: 20184934
Expert Opin Drug Deliv. 2008 Jul;5(7):775-88
pubmed: 18590462
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Acta Pharm Sin B. 2015 Sep;5(5):402-18
pubmed: 26579471
Urol Oncol. 2008 Jan-Feb;26(1):57-64
pubmed: 18190833
J Control Release. 2020 Aug 10;324:146-155
pubmed: 32389777
Mol Oncol. 2012 Apr;6(2):222-36
pubmed: 22406404
J Manag Care Pharm. 2012 Nov-Dec;18(9):713-8
pubmed: 23206214
Cancers (Basel). 2021 Jul 03;13(13):
pubmed: 34283075
Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):E1278-87
pubmed: 25733851
Biochem Pharmacol. 2012 Apr 15;83(8):1104-11
pubmed: 22285912
Neuro Oncol. 2003 Apr;5(2):79-88
pubmed: 12672279
J Immunother Cancer. 2019 Feb 8;7(1):37
pubmed: 30736857
Med Oncol. 2017 Dec 18;35(1):13
pubmed: 29255938
ACS Chem Biol. 2013 Jul 19;8(7):1389-95
pubmed: 23590228
Drug Deliv. 2016 Oct;23(8):2677-2685
pubmed: 26171813
Pharmaceuticals (Basel). 2021 Dec 17;14(12):
pubmed: 34959723
Neoplasia. 2020 Nov;22(11):539-553
pubmed: 32966956
Sci Rep. 2017 Mar 06;7:43271
pubmed: 28262735
Adv Drug Deliv Rev. 2013 May;65(5):703-18
pubmed: 23000745
Int J Radiat Oncol Biol Phys. 2019 Feb 1;103(2):335-343
pubmed: 30312717
Mater Sci Eng C Mater Biol Appl. 2021 Jan;118:111384
pubmed: 33254991
Breast Cancer Res. 2018 Sep 5;20(1):108
pubmed: 30185216
Annu Int Conf IEEE Eng Med Biol Soc. 2021 Nov;2021:7399-7403
pubmed: 34892807
Int J Biol Macromol. 2019 Sep 1;136:48-56
pubmed: 31195043
Cancer Sci. 2021 Jul;112(7):2592-2606
pubmed: 33938090
Int J Nanomedicine. 2012;7:1043-60
pubmed: 22403487
Dis Model Mech. 2014 Feb;7(2):299-309
pubmed: 24713276
JAMA. 2019 Jan 22;321(3):288-300
pubmed: 30667505
Biomaterials. 2020 Feb;230:119618
pubmed: 31757530
Biomed Mater. 2009 Apr;4(2):022001
pubmed: 19261988
Int J Nanomedicine. 2017 Mar 27;12:2373-2384
pubmed: 28392694
Int J Mol Sci. 2021 Oct 21;22(21):
pubmed: 34768800
Breast Cancer Res. 2021 Oct 30;23(1):100
pubmed: 34717714
J Control Release. 2001 Jul 6;74(1-3):317-23
pubmed: 11489513
ACS Biomater Sci Eng. 2021 Aug 9;7(8):3470-3486
pubmed: 34286955
Nanomedicine (Lond). 2012 Aug;7(8):1253-71
pubmed: 22931450
Nat Protoc. 2017 Apr;12(4):639-663
pubmed: 28253234
Breast Cancer (Dove Med Press). 2018 Sep 11;10:131-141
pubmed: 30237735
Adv Mater. 2018 Aug;30(31):e1706665
pubmed: 29756237
Eur J Pharmacol. 2020 Dec 15;889:173605
pubmed: 32980347
BMC Med. 2015 Aug 17;13:195
pubmed: 26278220
J Cell Physiol. 2000 Mar;182(3):311-22
pubmed: 10653597
Colloids Surf B Biointerfaces. 2013 Nov 1;111:117-23
pubmed: 23787278
PLoS One. 2013 Oct 30;8(10):e78043
pubmed: 24205081
Clin Cancer Res. 2008 Mar 1;14(5):1310-6
pubmed: 18316549
Nanotechnol Sci Appl. 2008 Sep 19;1:17-32
pubmed: 24198458
Am J Respir Crit Care Med. 2005 Dec 15;172(12):1487-90
pubmed: 16151040
Small. 2020 Mar;16(9):e1902262
pubmed: 31322830
Breast Cancer Res Treat. 2022 Jan;191(2):257-267
pubmed: 34731350
Front Immunol. 2021 Jul 29;12:723544
pubmed: 34394131
Chirurgia (Bucur). 2017 Jul-Aug;112(4):413-417
pubmed: 28862117
Adv Healthc Mater. 2017 Jan;6(2):
pubmed: 27886461
J Control Release. 2001 Jul 10;75(1-2):1-10
pubmed: 11451492
Biomaterials. 2012 Nov;33(33):8442-50
pubmed: 22922025